19 November 2026
Latham & Watkins Advises on Ardent Health’s Secondary Offering
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Erika Weinberg Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Lindsey Mills | Latham & Watkins LLP | Counsel | Capital Markets | New York |
| Matthew Dwelle | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Renad Alqarni | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 14.5 (US$14.50 per share)
- What the figure measures
- Per share
- Client
- Not stated
- Counterparties
- Ardent Health, Inc. (Issuer)
Equity Group Investments (Sell-side)
Ventas, Inc. (Sell-side)